Allstate Corporation’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$453K Sell
3,239
-7,952
-71% -$1.01M ﹤0.01% 1075
2026
Q1
$1.2M Buy
+11,191
New +$1.26M 0.01% 739
2022
Q1
Sell
-10,243
Closed -$455K 657
2021
Q4
$455K Buy
10,243
+3,693
+56% +$170K 0.01% 687
2021
Q3
$316K Buy
6,550
+2,636
+67% +$146K 0.01% 617
2021
Q2
$332K Sell
3,914
-760
-16% -$62.4K 0.01% 629
2021
Q1
$392K Sell
4,674
-600
-11% -$52.8K 0.01% 603
2020
Q4
$397K Hold
5,274
0.01% 565
2020
Q3
$261K Buy
+5,274
New +$232K 0.01% 600

Other funds holding GKOS

Allstate Corporation's GKOS Position: Q2 2026 in Review

Allstate Corporation reduced its Glaukos (GKOS) stake by 71% in Q2 2026, selling an estimated $1.01M and leaving 3,239 shares worth $453K. The position accounts for ﹤0.01% of the portfolio, ranked #1075.

Allstate Corporation first reported a position in GKOS in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.2M in Q1 2026. 367 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Allstate Corporation held 3,239 shares of Glaukos worth $453K as of Q2 2026.
  • Allstate Corporation sold 7,952 Glaukos shares in Q2 2026, an estimated $1.01M.
  • Glaukos made up ﹤0.01% of Allstate Corporation's portfolio in Q2 2026, its #1075 holding.
  • Allstate Corporation first reported a position in Glaukos in Q3 2020 and has held it in 8 quarters since.
  • Allstate Corporation's Glaukos position peaked at $1.2M in Q1 2026.
  • 367 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.